Moberg's derma tech enters Phase II; West Pharma counting on delivery sales;

 @DamianFierce: Ever wonder exactly how wireless drug delivery works? Well, wonder no longer. News | Follow @DamianFierce

> Following positive Phase I results for Limtop, Sweden's Moberg Derma is launching Phase II trials for the dermal delivery technology. More

> West Pharma is betting on its proprietary drug delivery technologies to drive sales growth over the next 5 years. Report

> Medimetrics is touting the recent certification of the IntelliCap system, which is designed to deliver small-molecule drugs into the gastrointestinal tract. Article

> Diabecline, pharmaCline's antibiotic ointment that uses a proprietary delivery system, won bronze honors for Best New Pharmaceutical Product at the Edison Awards this month. Release

And Finally... Drug developers have spent millions in R&D to improve controlled-release platforms, but perhaps they could have saved time and money by just watching 1983's The Witches and copying Formula 86, a delayed-action mousemaker. Blog post

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.